c-kit delineates a distinct domain of progenitors in the developing kidney.
Early inductive events in mammalian nephrogenesis depend on an interaction between the ureteric bud and the metanephric mesenchyme. However, mounting evidence points towards an involvement of additional cell types--such as stromal cells and angioblasts--in growth and patterning of the nephron. In this study, through analysis of the stem cell factor (SCF)/c-kit ligand receptor pair, we describe an additional distinct cell population in the early developing kidney. While SCF is restricted to the ureteric bud, c-kit-positive cells are located within the renal interstitium, but are negative for Foxd1, an established marker of stromal cells. In fact, the c-kit-positive domain is continuous with a central mesodermal cell mass ventral and lateral to the dorsal aorta, while Foxd1-expressing stromal cells are continuous with a dorsal perisomitic cell population suggesting distinct intraembryonic origins for these cell types. A subset of c-kit-positive cells expresses Flk-1 and podocalyxin, suggesting that this cell population includes angioblasts and their progenitors. c-kit activation is not required for the survival of these cells in vivo, because white spotting (c-kit(W/W)) mice, carrying a natural inactivating mutation of c-kit, display normal intrarenal distribution of the c-kit-positive cells at E13.5. In addition, early kidney development in these mutants is preserved up to the stage when anemia compromises global embryonic development. In contrast, under defined conditions in organ cultures of metanephric kidneys, c-kit-positive cells, including the Flk-1-positive subset, undergo apoptosis after treatment with STI-571, an inhibitor of c-kit tyrosine phosphorylation. This is associated with reductions in ureteric bud branching and nephron number. Conversely, exogenous SCF expands the c-kit-positive population, including Flk-1-positive angioblasts, and accelerates kidney development in vitro. These data suggest that ureteric bud-derived SCF elicits growth-promoting effects in the metanephric kidney by expanding one or more components of the interstitial c-kit-positive progenitor pool.
Schmidt-Ott
Kai M
KM
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
Chen
Xia
X
Paragas
Neal
N
Levinson
Randy S
RS
Mendelsohn
Cathy L
CL
Barasch
Jonathan
J
D000818:Animals; D015415:Biomarkers; D019070:Cell Lineage; D051858:Forkhead Transcription Factors / Q000378:metabolism; D007668:Kidney / Q000166:cytology* / Q000196:embryology*; D051379:Mice; D009924:Organ Culture Techniques; D021381:Protein Transport; D019009:Proto-Oncogene Proteins c-kit / Q000378:metabolism*; D015398:Signal Transduction; D019089:Stem Cell Factor / Q000378:metabolism; D013234:Stem Cells / Q000166:cytology*; D017154:Stromal Cells / Q000166:cytology; D014513:Ureter / Q000166:cytology
D015415:Biomarkers; D051858:Forkhead Transcription Factors; C489562:Foxd1 protein, mouse; D019089:Stem Cell Factor; D019009:Proto-Oncogene Proteins c-kit